<?xml version="1.0" ?><!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st June 2018//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_180601.dtd"><PubmedArticleSet><PubmedArticle>    <MedlineCitation Status="In-Data-Review" Owner="NLM">        <PMID Version="1">30189117</PMID>        <DateRevised>            <Year>2018</Year>            <Month>11</Month>            <Day>14</Day>        </DateRevised>        <Article PubModel="Print-Electronic">            <Journal>                <ISSN IssnType="Electronic">1097-0142</ISSN>                <JournalIssue CitedMedium="Internet">                    <Volume>124</Volume>                    <Issue>17</Issue>                    <PubDate>                        <Year>2018</Year>                        <Month>Sep</Month>                        <Day>01</Day>                    </PubDate>                </JournalIssue>                <Title>Cancer</Title>                <ISOAbbreviation>Cancer</ISOAbbreviation>            </Journal>            <ArticleTitle>Trends in breast cancer mortality by stage at diagnosis among young women in the United States.</ArticleTitle>            <Pagination>                <MedlinePgn>3500-3509</MedlinePgn>            </Pagination>            <ELocationID EIdType="doi" ValidYN="Y">10.1002/cncr.31638</ELocationID>            <Abstract>                <AbstractText Label="BACKGROUND" NlmCategory="BACKGROUND">Assessing trends in breast cancer survival among young women who are largely unaffected by breast cancer screening will provide important information regarding improvements in the effectiveness of cancer care for breast cancer in the last few decades.</AbstractText>                <AbstractText Label="METHODS" NlmCategory="METHODS">The cohort for this study consisted of women who were diagnosed with breast cancer between ages 20 and 39 years from the Surveillance, Epidemiology, and End Results program's 9-registry areas from 1975 to 2015. Trends in the breast cancer incidence rate and survival were assessed among young women.</AbstractText>                <AbstractText Label="RESULTS" NlmCategory="RESULTS">Among women aged 20 to 39 years, breast cancer incidence increased from 24.6 per 100,000 in 1975 to 31.7 per 100,000 in 2015 (annual percent change, 0.5; 95% confidence interval [CI], 0.4-0.6). Among women with breast cancer, 5-year breast-cancer-specific survival increased significantly from 74.0% during 1975 to 1979 to 88.5% during 2010 to 2015 (hazard ratio for dying from breast cancer for 2010-2015 vs 1975-1979, 0.37; 95% CI, 0.32-0.41). The increase in cancer-specific survival reached a plateau in 2005; however, among young women with metastatic breast cancer, it continued to increase after 2005, from 45.6% during 2005 to 2009 to 56.5% during 2010 to 2015 (hazard ratio for dying from breast cancer for 2010-2015 vs 2005-2009, 0.74; 95% CI, 0.60-0.92). Similar patterns also were observed for 5-year overall survival and among women aged 20 to 29 years and those aged 30 to 39 years.</AbstractText>                <AbstractText Label="CONCLUSIONS" NlmCategory="CONCLUSIONS">There were substantial improvements in the effectiveness of breast cancer treatment on overall and cancer-specific survival from 1975 to 2015. However, improvements appeared to have reached a plateau after 2005, except among young women with metastatic breast cancer, in whom survival continued to improve throughout the period.</AbstractText>                <CopyrightInformation>Â© 2018 American Cancer Society.</CopyrightInformation>            </Abstract>            <AuthorList CompleteYN="Y">                <Author ValidYN="Y">                    <LastName>Guo</LastName>                    <ForeName>Fangjian</ForeName>                    <Initials>F</Initials>                    <Identifier Source="ORCID">http://orcid.org/0000-0003-3729-2724</Identifier>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Texas.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Kuo</LastName>                    <ForeName>Yong-Fang</ForeName>                    <Initials>YF</Initials>                    <AffiliationInfo>                        <Affiliation>Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Texas.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Office of Biostatistics, Department of Preventive Medicine and Community Health, The University of Texas Medical Branch at Galveston, Texas.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Institute for Translational Science, The University of Texas Medical Branch at Galveston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Shih</LastName>                    <ForeName>Ya Chen Tina</ForeName>                    <Initials>YCT</Initials>                    <AffiliationInfo>                        <Affiliation>Section of Cancer Economics and Policy, Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Giordano</LastName>                    <ForeName>Sharon H</ForeName>                    <Initials>SH</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Breast Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Department of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>                <Author ValidYN="Y">                    <LastName>Berenson</LastName>                    <ForeName>Abbey B</ForeName>                    <Initials>AB</Initials>                    <AffiliationInfo>                        <Affiliation>Department of Obstetrics and Gynecology, The University of Texas Medical Branch at Galveston, Texas.</Affiliation>                    </AffiliationInfo>                    <AffiliationInfo>                        <Affiliation>Center for Interdisciplinary Research in Women's Health, The University of Texas Medical Branch at Galveston, Texas.</Affiliation>                    </AffiliationInfo>                </Author>            </AuthorList>            <Language>eng</Language>            <GrantList CompleteYN="Y">                <Grant>                    <GrantID>R01 CA207216</GrantID>                    <Agency>National Cancer Institute</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>K12HD052023</GrantID>                    <Agency>Office of Research on Women's Health</Agency>                    <Country/>                </Grant>                <Grant>                    <GrantID>R01 CA207216</GrantID>                    <Acronym>CA</Acronym>                    <Agency>NCI NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <GrantID>K12 HD052023</GrantID>                    <Acronym>HD</Acronym>                    <Agency>NICHD NIH HHS</Agency>                    <Country>United States</Country>                </Grant>                <Grant>                    <Agency>Eunice Kennedy Shriver National Institute of Child Health and Human Development</Agency>                    <Country/>                </Grant>            </GrantList>            <PublicationTypeList>                <PublicationType UI="D016428">Journal Article</PublicationType>            </PublicationTypeList>            <ArticleDate DateType="Electronic">                <Year>2018</Year>                <Month>09</Month>                <Day>06</Day>            </ArticleDate>        </Article>        <MedlineJournalInfo>            <Country>United States</Country>            <MedlineTA>Cancer</MedlineTA>            <NlmUniqueID>0374236</NlmUniqueID>            <ISSNLinking>0008-543X</ISSNLinking>        </MedlineJournalInfo>        <CommentsCorrectionsList>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2004 Jun;5(6):372-80</RefSource>                <PMID Version="1">15172358</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2013 Feb 27;309(8):800-5</RefSource>                <PMID Version="1">23443443</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2016 Feb 16;164(4):215-25</RefSource>                <PMID Version="1">26756606</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2012 Feb 9;366(6):520-9</RefSource>                <PMID Version="1">22149876</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2012 Nov 8;367(19):1783-91</RefSource>                <PMID Version="1">23020162</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2012 Jun 20;30(18):2218-26</RefSource>                <PMID Version="1">22585699</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Radiology. 2016 Sep;280(3):716-22</RefSource>                <PMID Version="1">27097237</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Am J Public Health. 1987 Apr;77(4):495-7</RefSource>                <PMID Version="1">3826470</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2002 Jul 20;360(9328):187-95</RefSource>                <PMID Version="1">12133652</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2016 Nov 15;165(10):700-712</RefSource>                <PMID Version="1">27548583</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2014 May;15(6):580-91</RefSource>                <PMID Version="1">24742739</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Br J Cancer. 2005 Aug 8;93(3):293-301</RefSource>                <PMID Version="1">16052223</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2016 Oct 13;375(15):1438-1447</RefSource>                <PMID Version="1">27732805</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Compr Canc Netw. 2009 Nov;7(10):1060-96</RefSource>                <PMID Version="1">19930975</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Apr 1;34(10):1134-50</RefSource>                <PMID Version="1">26858339</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2017 Mar;67(2):100-121</RefSource>                <PMID Version="1">28170086</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2009 Nov 17;151(10):716-26, W-236</RefSource>                <PMID Version="1">19920272</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Oncol. 2015 Mar;26(3):523-8</RefSource>                <PMID Version="1">25480878</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2006 Oct;99(3):333-40</RefSource>                <PMID Version="1">16703451</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2007 Jul 12;357(2):115-23</RefSource>                <PMID Version="1">17625123</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2001 Oct 27;358(9291):1389-99</RefSource>                <PMID Version="1">11705483</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>BMJ. 2010 Aug 11;341:c3620</RefSource>                <PMID Version="1">20702548</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2007 Jul 5;357(1):39-51</RefSource>                <PMID Version="1">17611206</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>CA Cancer J Clin. 2016 Jan-Feb;66(1):31-42</RefSource>                <PMID Version="1">26513636</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res. 2009;11(4):R44</RefSource>                <PMID Version="1">19575807</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2016 Sep 20;34(27):3308-14</RefSource>                <PMID Version="1">27480155</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Treat Rev. 2013 Aug;39(5):507-17</RefSource>                <PMID Version="1">23102614</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Prev Med. 2013 May;56(5):309-13</RefSource>                <PMID Version="1">23428566</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Obstet Gynecol. 2011 Aug;118(2 Pt 1):372-82</RefSource>                <PMID Version="1">21775869</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Breast Cancer Res Treat. 2013 Apr;138(3):665-73</RefSource>                <PMID Version="1">23546552</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stat Med. 2000 Feb 15;19(3):335-51</RefSource>                <PMID Version="1">10649300</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Am Coll Radiol. 2013 Jan;10(1):11-4</RefSource>                <PMID Version="1">23290667</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Stat Methods Med Res. 2006 Dec;15(6):547-69</RefSource>                <PMID Version="1">17260923</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>N Engl J Med. 2001 Mar 15;344(11):783-92</RefSource>                <PMID Version="1">11248153</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Surg Oncol. 2013 Oct;20(10):3254-8</RefSource>                <PMID Version="1">23975317</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Cancer Epidemiol Biomarkers Prev. 1999 Dec;8(12):1117-21</RefSource>                <PMID Version="1">10613347</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Ann Intern Med. 2009 Nov 17;151(10):738-47</RefSource>                <PMID Version="1">19920274</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>JAMA. 2011 Nov 2;306(17):1884-90</RefSource>                <PMID Version="1">22045766</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Natl Compr Canc Netw. 2014 Apr;12(4):542-90</RefSource>                <PMID Version="1">24717572</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet Oncol. 2013 May;14(6):461-71</RefSource>                <PMID Version="1">23602601</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>Lancet. 2003 Apr 26;361(9367):1405-10</RefSource>                <PMID Version="1">12727392</PMID>            </CommentsCorrections>            <CommentsCorrections RefType="Cites">                <RefSource>J Clin Oncol. 2015 Nov 1;33(31):3621-7</RefSource>                <PMID Version="1">26371147</PMID>            </CommentsCorrections>        </CommentsCorrectionsList>        <KeywordList Owner="NOTNLM">            <Keyword MajorTopicYN="N">breast cancer</Keyword>            <Keyword MajorTopicYN="N">ductal carcinoma in situ (DCIS)</Keyword>            <Keyword MajorTopicYN="N">incidence</Keyword>            <Keyword MajorTopicYN="N">survival</Keyword>        </KeywordList>    </MedlineCitation>    <PubmedData>        <History>            <PubMedPubDate PubStatus="received">                <Year>2018</Year>                <Month>01</Month>                <Day>26</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="revised">                <Year>2018</Year>                <Month>05</Month>                <Day>22</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="accepted">                <Year>2018</Year>                <Month>05</Month>                <Day>24</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pmc-release">                <Year>2019</Year>                <Month>09</Month>                <Day>06</Day>            </PubMedPubDate>            <PubMedPubDate PubStatus="pubmed">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="medline">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>            <PubMedPubDate PubStatus="entrez">                <Year>2018</Year>                <Month>9</Month>                <Day>7</Day>                <Hour>6</Hour>                <Minute>0</Minute>            </PubMedPubDate>        </History>        <PublicationStatus>ppublish</PublicationStatus>        <ArticleIdList>            <ArticleId IdType="pubmed">30189117</ArticleId>            <ArticleId IdType="doi">10.1002/cncr.31638</ArticleId>            <ArticleId IdType="pmc">PMC6191354</ArticleId>            <ArticleId IdType="mid">NIHMS974208</ArticleId>        </ArticleIdList>    </PubmedData></PubmedArticle></PubmedArticleSet>